CN Patent

CN101406471A — 具有β-内酰胺酶抑制剂活性的新的杂环化合物

Assigned to Novexel SA · Expires 2009-04-15 · 17y expired

What this patent protects

本发明涉及具有β－内酰胺酶抑制剂活性的新的杂环化合物，即式(I)化合物及其可药用盐在制备用于抑制致病菌产生β－内酰胺酶的药物中的用途。

USPTO Abstract

本发明涉及具有β－内酰胺酶抑制剂活性的新的杂环化合物，即式(I)化合物及其可药用盐在制备用于抑制致病菌产生β－内酰胺酶的药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number: CN101406471A
Jurisdiction: CN
Classification: —
Expires: 2009-04-15
Drug substance claim: No
Drug product claim: No
Assignee: Novexel SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.